retatrutide fda approval status october 2025 Demand for Unapproved Weight-Loss Drug Surges on Social Media What is Retatrutide? 👇 A

Research published in Endocrinology (Clemmensen et al., 2013) demonstrated that oral L-arginine increased plasma GLP-1 and insulin in both lean and obese mice, substantially improving glucose clearance

Members of Second Natures Mounjaro programme have also reported experiencing this side effect

The improved insulin sensitivity from both Retatrutide and testosterone enhances nutrient partitioning toward muscle tissue

Its FDA-approved and widely available

Multi-society consensus guidelines have, in general, recommended an individualized approach toward the decision to withhold GLP-1RA therapy (46)

Wegovy contains the same active ingredient as Ozempic, but is delivered at a higher maintenance dose (2.4 mg of semaglutide weekly versus 2 mg for Ozempic)